Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study
Authors:
- 21 April 2025
- journal article
- Published by Elsevier in Seminars in Arthritis and Rheumatism
- Vol. 73, 152735
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War (PR200793)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30 AR072583)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (I01 BX003635)
- National Institutes of Health
- Rehabilitation Research and Development Service
- Clinical Science Research and Development
- Health Services Research and Development
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- National Institute of General Medical Sciences (2U54GM115458)
- National Institute of General Medical Sciences (P20 GM130423)
- U.S. Department of Veterans Affairs (IK2 CX002203)
- U.S. Department of Veterans Affairs (CX001703)
- U.S. Department of Veterans Affairs (RX003644)
- Rheumatology Research Foundation
This publication has 38 references indexed in Scilit:
- Extracting forced vital capacity from the electronic health record through natural language processing in rheumatoid arthritis‐associated interstitial lung diseasePharmacoepidemiology and Drug Safety, 2023
- Target Trial EmulationJAMA, 2022
- A retrospective study of the efficacy of JAK inhibitors or abatacept on rheumatoid arthritis-interstitial lung diseaseInflammopharmacology, 2022
- What Is Rheumatoid Arthritis?JAMA, 2022
- Abatacept in rheumatoid arthritis-associated interstitial lung disease: short-term outcomes and predictors of progressionClinical Rheumatology, 2021
- Rheumatoid arthritis–associated interstitial lung disease: an overview of epidemiology, pathogenesis and managementClinical Rheumatology, 2020
- Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid ArthritisArthritis Care & Research, 2019
- Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis–Associated Interstitial Lung Disease: A Prospective Cohort StudyArthritis & Rheumatology, 2019
- Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid ArthritisArthritis Care & Research, 2016
- Merging Veterans Affairs rheumatoid arthritis registry and pharmacy data to assess methotrexate adherence and disease activity in clinical practiceArthritis Care & Research, 2011